A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND A supervised injection facility (SIF) has been established in North America: Insite, in Vancouver, British Columbia. The purpose of this paper is to conduct a cost-effectiveness and cost-benefit analysis of this SIF using secondary data gathered and analysed in 2008. In using these data we seek to determine whether the facility's prevention of infections and deaths among injecting drug users (IDUs) is of greater or lesser economic cost than the cost involved in providing this service - Insite - to this community. METHODS Mathematical modelling is used to estimate the number of new HIV infections and deaths prevented each year. We use the number of these new HIV infections and deaths prevented, in conjunction with estimated lifetime public health care costs of a new HIV infection, and the value of a life, in order to calculate an identifiable portion of the societal benefits of Insite. The annual costs of operating the SIF are used to measure the social costs of Insite. In using this information, we calculate cost-effectiveness and benefit-cost ratios for the SIF. RESULTS Through the use of conservative estimates, Vancouver's SIF, Insite, on average, prevents 35 new cases of HIV and almost 3 deaths each year. This provides a societal benefit in excess of $6 million per year after the programme costs are taken into account, translating into an average benefit-cost ratio of 5.12:1. CONCLUSION Vancouver's SIF appears to be an effective and efficient use of public health care resources, based on a modelling study of only two specific and measurable benefits-HIV infection and overdose death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic
Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., & Schechter, M. T. (2003) · AIDS · doi:10.1097/00002030-200304110-00014 · Cited by 373
Safer injection facility use and syringe sharing in injection drug users
Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66475-6 · Cited by 294
Research works printed but not linked: 30
- Chen, 2006, Distribution of health care expenditures for HIV-infected patients, Clinical Infectious Diseases, 42, 1003, 10.1086/500453 · DOI · Paper page
- Coffin, 2003, Opiates, cocaine, and alcohol combinations in accidental drug overdose deaths in New York City 1990–98, Addiction, 98, 739, 10.1046/j.1360-0443.2003.00376.x · DOI · Paper page
- Cohen, 2004, Willingness-to-pay for crime control programs, Criminology, 42, 89, 10.1111/j.1745-9125.2004.tb00514.x · DOI · Paper page
- Davidson, 2003, Fatal heroin-related overdose in San Francisco, 1997–2000: A case for targeted intervention, Journal of Urban Health, 80, 261, 10.1093/jurban/jtg029 · DOI · Paper page
- Des Jarlais, 1992, International epidemiology among injecting drug users, AIDS, 6, 1053, 10.1097/00002030-199210000-00001 · doi:10.1097/00002030-199210000-00001
- Des Jarlais, 1996, HIV incidence among injecting drug users in New York City syringe-exchange programmes, Lancet, 348, 987, 10.1016/S0140-6736(96)02536-6 · DOI · Paper page
- Frei, 2000, Socioeconomic evaluation of heroin maintenance treatment final report, Vol. 2, 37
- Gold, 1997, Needle exchange programs: An economic evaluation of a local experience, Canadian Medical Association Journal, 157, 255
- Grover, 1993, A prospective study of direct health care costs of HIV infected adults in Canada [abstract PO-D28-4226], International Conference on AIDS, 9, 922
- Holtgrave, 1997, Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 55, 10.1097/00042560-199709010-00009 · DOI · Paper page
- Holtgrave, 1998, Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S133, 10.1097/00042560-199802001-00022 · DOI
- Jacobs, 1999, Cost effectiveness of Streetworks’ needle exchange program of Edmonton, Canadian Journal of Public Health, 90, 168, 10.1007/BF03404500 · doi:10.1007/bf03404500
- Kaplan, 1993, Let the needles to the talking! Evaluating the New Haven needle exchange, Interfaces, 23, 7, 10.1287/inte.23.1.7 · doi:10.1287/inte.23.1.7
- Kerr, 2005, Potential use of safer injecting facilities among injection drug users in Vancouver's downtown eastside, Canadian Medical Association Journal, 169, 759
- Kerr, 2006, Impact of a medically supervised safer injection facility on community drug use patterns: A before and after study, British Medical Journal, 332, 220, 10.1136/bmj.332.7535.220 · DOI
- Kerr, 2006, Drug-related overdoses within a medically supervised safer injection facility, International Journal of Drug Policy, 17, 436, 10.1016/j.drugpo.2006.05.008 · DOI
- Kimber, 2003, Drug consumption facilities: An update since 2000, Drug and Alcohol Review, 22, 227, 10.1080/095952301000116951 · DOI · Paper page
- Kimber, 2005, A survey of drug consumption rooms: Service delivery and perceived public health and amenity impact, Drug and Alcohol Review, 24, 21, 10.1080/09595230500125047 · DOI
- Kleinig, 2006, Thinking ethically about needle and syringe programs, Substance Use and Misuse, 41, 815, 10.1080/10826080600668670 · DOI
- Laufer, 2001, Cost-effectiveness of syringe exchanges as an HIV prevention strategy, Journal of Acquired Immune Deficiency Syndromes, 28, 273, 10.1097/00042560-200111010-00012 · doi:10.1097/00042560-200111010-00012
- Lert, 2007, Antiretroviral HIV treatment and care for injecting drug users: An evidence-based overview, International Journal of Drug Policy, 18, 255, 10.1016/j.drugpo.2007.05.002 · doi:10.1016/j.drugpo.2007.05.002
- Petrar, 2007, Injection drug users’ perceptions regarding use of a medically supervised safer injection facility, Addictive Behaviors, 32, 1088, 10.1016/j.addbeh.2006.07.013 · DOI
- Siegel, 1991, Bleach programs for preventing AIDS among IV drug users: Modelling the impact of HIV prevalence, American Journal of Public Health, 81, 1273, 10.2105/AJPH.81.10.1273 · DOI
- Tyndall, 2006, Attendance, drug use patterns, and referrals made from North America's first supervised injection facility, Drug and Alcohol Dependence, 83, 193, 10.1016/j.drugalcdep.2005.11.011 · DOI
- Tyndall, 2006, HIV seroprevalence along participants of a supervised injection facility in Vancouver, Canada, Harm Reduction Journal, 3, 36, 10.1186/1477-7517-3-36 · DOI
- Vlahov, 1998, The role of needle exchange programs in HIV prevention, Public Health Reports, 113, 75
- Watters, 1994, Syringe and needle exchange as HIV/AIDS prevention for injection drug users, Journal of the American Medical Association, 271, 115, 10.1001/jama.271.2.115 · doi:10.1001/jama.271.2.115 · Paper page
- Wood, 2001, Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?, Canadian Medical Association Journal, 165, 405
- Wood, 2005, Factors associated with syringe sharing among users of a medically supervised safer injecting facility, American Journal of Infectious Diseases, 1, 50, 10.3844/ajidsp.2005.50.54 · DOI
- Wood, 2006, Attendance of supervised injecting facilities and use of detoxification services, New England Journal of Medicine, 354, 2512, 10.1056/NEJMc052939 · DOI · Paper page
Cited by
Supervised injection services: What has been demonstrated? A systematic literature review
Potier, C., Laprévote, V., Dubois-Arber, F., Cottencin, O., & Rolland, B. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.012 · Cited by 495
Return on investment of public health interventions: a systematic review
Masters, R., Anwar, E., Collins, B., Cookson, R., & Capewell, S. (2017) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2016-208141 · Cited by 480
Degenhardt, L., Mathers, B., Vickerman, P., Rhodes, T., Latkin, C., & Hickman, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60742-8 · Cited by 423
Kennedy, M. C., Karamouzian, M., & Kerr, T. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0363-y · Cited by 256
Milloy, M.-J. S., Kerr, T., Tyndall, M., Montaner, J., & Wood, E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003351 · Cited by 117
“Our results differ from those in an unpublished cost-effectiveness report prepared for Canada's federal health minister”
Result
Metadata
- Authors
- Andresen, M. A., & Boyd, N.
- Venue
- International Journal of Drug Policy
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 21
- Issue
- 1
- Pages
- 70-76
- ISSN
- 0955-3959 (ISSN-L)
- OpenAlex
- W2165639864
- Cited by
- 154
- References
- 2
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. https://app.cochat.ai/papers/10.1016/j.drugpo.2009.03.004
- The paper
- Andresen, M. A., & Boyd, N. (2010). A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2009.03.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.